5
The Blurring of Boundaries in Biopharmaceutical Supply Chains: The Case of Oncology Medicine
INTRODUCTION
In response to the massive structural and infrastructural changes that are occurring on the horizon, supply chains in the life sciences and biopharmaceutical industries are changing rapidly. The rise of pay-for-performance, bundled payments, increasing power of payers, personalized medicine, and shrinking public medical payment rates are forcing ...
Get Biopharmaceutical Supply Chains now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
